WO2017060397A1 - Methods for predicting the survival time of subjects suffering from melanoma metastases - Google Patents

Methods for predicting the survival time of subjects suffering from melanoma metastases Download PDF

Info

Publication number
WO2017060397A1
WO2017060397A1 PCT/EP2016/073951 EP2016073951W WO2017060397A1 WO 2017060397 A1 WO2017060397 A1 WO 2017060397A1 EP 2016073951 W EP2016073951 W EP 2016073951W WO 2017060397 A1 WO2017060397 A1 WO 2017060397A1
Authority
WO
WIPO (PCT)
Prior art keywords
hvem
antibody
expression
survival time
subject
Prior art date
Application number
PCT/EP2016/073951
Other languages
French (fr)
Inventor
Daniel Olive
Nausicaa MALISSEN
Nicolas MACAGNO
Jean-Jacques GROB
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Université D'aix Marseille
Institut Jean Paoli & Irene Calmettes
Centre National De La Recherche Scientifique (Cnrs)
Assistance Publique Hôpitaux De Marseille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP15306601 priority Critical
Priority to EP15306601.4 priority
Priority to EP15306637.8 priority
Priority to EP15306637 priority
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Université D'aix Marseille, Institut Jean Paoli & Irene Calmettes, Centre National De La Recherche Scientifique (Cnrs), Assistance Publique Hôpitaux De Marseille filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Publication of WO2017060397A1 publication Critical patent/WO2017060397A1/en

Links